EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Association Between High Serum Aspartate Transaminase to Alanine Transaminase Ratio and Probable HIV Dementia Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy: A Cross-Sectional Study from Central Uganda

Charles Nkubi Bagenda iD, Carol Nantongo, Michael Junior Mugisa iD, Vincent Olwoch, Fauziya Naziiwa, Christier Masereka, Bright Bagambe, Godfrey Somikwo, Fred Sempijja, Jazira Tumusiime, Deusdedit Tusubira

Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2026-01 · 25

DOI: 10.1177/23259582261475552 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), online erschienen am 03.08.2026. Verfasst von Charles Nkubi Bagenda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, Faculty of Health Sciences, Mbarara University of Science and Technology, Mbarara, Uganda. Hauptthemen laut MEDLINE: AIDS Dementia Complex, Heterocyclic Compounds, 3-Ring, HIV Infections, Alanine Transaminase. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Probable HIV dementia (PHD) remains a significant complication among people living with HIV(PLWH), particularly in resource-limited settings where access to comprehensive neurocognitive assessment is limited . This study investigated the association between AST-to-ALT ratio and PHD among PLWH on Dolutegravir-based antiretroviral therapy (DTG-based ART).

Methods

We conducted a secondary analysis using a dataset generated from hospital-based cross-sectional study that consecutively recruited 235 PLWH on DTG-based ART at St. Francis Nsambya Hospital in Kampala, Central Uganda. PHD was defined as International HIV Dementia Scale score ≤10.

Results

PHD prevalence was 22.1% (52/235; 95% CI: 17.3–27.9) and increased across AST-to-ALT ratio tertiles (13%, 23%, and 31%; p=0.023). Participants in the second and third tertiles had higher odds of PHD (aOR=2.85, 95% CI: 1.13–7.15; p=0.026 and aOR=4.28, 95% CI: 1.75–10.45; p=0.001). Each 0.5-unit increase in the AST-to-ALT ratio increased the odds of PHD by 40% (aOR=1.40, 95% CI: 1.02–1.92; p=0.036). An AST-to-ALT ratio cutoff of 1.26 showed modest discrimination for PHD (AUC=0.622), with 73% sensitivity, 51% and specificity, 29%.

Conclusion

A higher AST-to-ALT ratio is a potentially useful screening predictor for PHD in PLWH on DTG-based ART in resource limited settings, pending validation in larger prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AIDS Dementia ComplexHeterocyclic Compounds, 3-RingHIV InfectionsAlanine TransaminaseAspartate AminotransferasesHumansCross-Sectional StudiesFemalePyridonesMaleDolutegravirOxazinesPiperazinesUgandaAdultMiddle AgedAnti-HIV Agents

Stichwörter der Autor:innen

alanine transaminaseaspartate transaminasedementiapredictorratio

Substanzen

PyridonesHeterocyclic Compounds, 3-RingDolutegravirOxazinesPiperazinesAlanine TransaminaseAspartate AminotransferasesAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, Faculty of Health Sciences, Mbarara University of Science and Technology, Mbarara, Uganda.
  • Department of Medical Laboratory Science, Uganda Institute of Allied Health and Management Sciences, Kampala, Uganda.
  • Department of Medical Laboratory, Joint Clinical Research Centre, Kampala, Uganda.
  • Department of Medical Laboratory Technology, Mayanja Memorial Medical Training Institute, Mbarara, Uganda.
  • Department of Biochemistry, Faculty of Health Sciences, Mbarara University of Science and Technology, Mbarara, Uganda.

ORCID-Profile: Charles Nkubi Bagenda, Michael Junior Mugisa

Zitieren

APA

Bagenda, C. N., Nantongo, C., Mugisa, M. J., Olwoch, V., Naziiwa, F., Masereka, C., Bagambe, B., Somikwo, G., Sempijja, F., Tumusiime, J., & Tusubira, D. (2026). Association Between High Serum Aspartate Transaminase to Alanine Transaminase Ratio and Probable HIV Dementia Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy: A Cross-Sectional Study from Central Uganda. Journal of the International Association of Providers of AIDS Care (JIAPAC), 25. https://doi.org/10.1177/23259582261475552

Vancouver

Bagenda CN, Nantongo C, Mugisa MJ, Olwoch V, Naziiwa F, Masereka C, et al. Association Between High Serum Aspartate Transaminase to Alanine Transaminase Ratio and Probable HIV Dementia Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy: A Cross-Sectional Study from Central Uganda. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2026;25. doi:10.1177/23259582261475552

BibTeX
@article{Bagenda2026,
  author = {Bagenda, Charles Nkubi and Nantongo, Carol and Mugisa, Michael Junior and Olwoch, Vincent and Naziiwa, Fauziya and Masereka, Christier and Bagambe, Bright and Somikwo, Godfrey and Sempijja, Fred and Tumusiime, Jazira and Tusubira, Deusdedit},
  title = {Association Between High Serum Aspartate Transaminase to Alanine Transaminase Ratio and Probable HIV Dementia Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy: A Cross-Sectional Study from Central Uganda},
  journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
  year = {2026},
  volume = {25},
  doi = {10.1177/23259582261475552}
}
Kostenlos starten →